KULR Technology Group (NYSE: KULR), a leader in advanced energy management, has expanded its Bitcoin Treasury with an additional $21 million investment, bringing its total bitcoin acquisitions to $42 million. These purchases were made at an average price of $98,393.58 per bitcoin, including fees and expenses. This move aligns with the company’s Bitcoin Treasury Strategy, […]
MicroCloud Hologram Advances Quantum Technology with High-Fidelity Qubit Control
MicroCloud Hologram (HOLO) has unveiled a groundbreaking advancement in quantum technology: a fast adiabatic driving protocol for achieving coherent control of two heavy hole spin qubits in a double quantum dot (QD) system. This innovative approach surpasses traditional quantum control methods, offering significant improvements in fidelity and stability for quantum information processing. A Leap Beyond […]
MySize Reports Strong Revenue Growth and Expands Global Footprint
MySize, Inc. (NASDAQ: MYSZ), a global leader in AI-powered sizing solutions and omnichannel e-commerce platforms, has released its annual shareholder update, showcasing a year of impressive growth, strategic advancements, and promising future opportunities. Delivering on Revenue and Efficiency MySize projects closing 2024 with $8.5 million in revenue, marking a 23% year-over-year increase. The company attributes […]
Telomir Pharmaceuticals Advances Copper-Binding Research with Telomir-1
Telomir Pharmaceuticals (TELO), a trailblazer in age-reversal research, has announced groundbreaking results demonstrating Telomir-1’s exceptional copper-binding properties. This advancement bolsters the compound’s potential to treat Wilson’s disease, a rare genetic disorder caused by toxic copper accumulation. The findings also expand Telomir’s focus on developing innovative therapies for critical medical challenges. Copper Regulation and Wilson’s Disease […]
Traws Pharma Advances H5N1 Bird Flu Treatment with Promising Data
Traws Pharma (TRAW), a clinical-stage biotech firm focused on respiratory viral diseases, has reported significant progress in the development of its investigational treatment for H5N1 bird flu, tivoxavir marboxil. This breakthrough comes at a time when avian flu is increasingly recognized as a potential global health threat. Dr. Robert R. Redfield, Chief Medical Officer at […]
European Markets Open Higher Amid Holiday Week, Novo Nordisk Rebounds
Markets Begin Festive Week on a Positive Note as Novo Nordisk Recovers From Friday’s Plunge European markets started the week on a positive trajectory, with the pan-European Stoxx 600 index gaining 0.4% in early Monday trading. Most sectors posted gains as investors settled into a shortened trading week ahead of the Christmas holiday. Positive Momentum […]
PainReform Soars 500% in a Single Day: What’s Driving the Surge?
PainReform Ltd. (NASDAQ: PRFX), a clinical-stage pharmaceutical company specializing in innovative pain management solutions, experienced an extraordinary 500% surge in its stock price today. This dramatic rise has caught the attention of investors and analysts alike, raising questions about the factors fueling such rapid growth. A Breakthrough in Pain Management PainReform is focused on addressing […]
Ideal Power Secures Pivotal Design Win for Solid-State Circuit Breakers
Ideal Power (NASDAQ: IPWR), a pioneer in energy-efficient semiconductor power switches, announced a significant breakthrough today by securing its first design win for solid-state circuit breakers (SSCBs). This collaboration is with one of Asia’s largest circuit protection equipment manufacturers, a leader in serving industrial and utility markets. This milestone agreement marks the beginning of a […]
MIRA Pharmaceuticals Moves Closer to Human Trials for Ketamir-2
MIRA Pharmaceuticals (MIRA), a preclinical-stage pharmaceutical company, has announced promising results from safety studies on Ketamir-2, a novel oral ketamine analog. The findings, which reveal no safety concerns, mark a major milestone as the company prepares for Phase 1 human trials in early 2025. “Advancing Ketamir-2 into clinical trials reflects our dedication to creating a […]
Pioneering B-TRAN Technology to Expand Applications in EVs, Renewable Energy, and Data Centers
Ideal Power (IPWR) has announced a significant milestone in its commercialization journey with a multi-unit order for its SymCool IQ intelligent power module. The order comes from a customer specializing in circuit protection and power conversion solutions, marking a promising expansion of Ideal Power’s market reach. The customer, already familiar with Ideal Power’s SymCool power […]